Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Claritin for G-CSF-induced Bone Pain
NCT03883386Phase 2Terminated
- Sponsor
- University of Michigan
- Start
- Jun 2019
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of loratadine in bone pain, sponsored by University of Michigan. Started Jun 2019; status: terminated.
02
Drugs
loratadine
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT03883386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883386.